Optimising recruitment in clinical trials for progressive multiple sclerosis: observational analysis from the MS-SMART and MS-STAT2 randomised controlled trials.

Thomas E WilliamsSarah AlexanderJames BlackstoneFloriana De AngelisNevin JohnAnisha DoshiJudy BeveridgeMarie BraisherEmma GrayJeremy Chatawaynull null

Published in: Trials (2022)

MS-SMART: NCT01910259 ; registered July 2013 and MS-STAT2: NCT03387670 ; registered Jan 2018.

Keyphrases

multiple sclerosis
mass spectrometry
ms ms
clinical trial
white matter
cell proliferation
study protocol
double blind